先看重点
在62人参与的跑步机测试中,Apple Watch的心率误差(MAPE)为1.14%至6.70%,Fitbit Charge HR为2.38%至16.99%,Garmin Forerunner 225为7.87%至24.38%,三者的热量估算误差都大得多。这些是当年的腕式设备,只在短时间实验室测试中评估,不代表现在的型号或日常使用情况。
证据类型
测量验证研究/综述
解读依据
公开摘要
阅读重点
参照与测量误差
研究在问什么
腕式运动设备被广泛用来判断心率和消耗热量,甚至用于减重干预,但运动越来越剧烈时它们是否仍然准确,此前并不清楚。研究者检验了三款常见设备在不同运动强度下测量心率和能量消耗的准确性。
研究了谁,如何研究
这是一项验证研究,62名参与者(女性占58%,非白人占47%)同时佩戴Apple Watch、Fitbit Charge HR和Garmin Forerunner 225。心率以胸带为参照,能量消耗以代谢车为参照。流程为10分钟静坐基线期,分别进行4分钟的轻度、中度和剧烈强度跑步机运动,再接10分钟静坐恢复期。设备数据与各参照标准用双因素重复测量方差分析和Bland-Altman分析比较,误差以平均绝对百分比误差(MAPE)表示。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 1Apple Watch的心率MAPE为1.14%至6.70%。在开始时(P=.78)、基线期(P=.76)和剧烈强度(P=.84)与胸带无差异,但在轻度(P=.03)、中度强度(P=.001)和恢复期(P=.004)读数偏低。
- 2Fitbit的心率MAPE为2.38%至16.99%。开始时(P=.67)和中度强度(P=.34)无差异,基线期、剧烈强度和恢复期读数偏低(P<.001),轻度强度偏高(P<.001)。
- 3Garmin的心率MAPE为7.87%至24.38%。仅在剧烈强度(P=.35)无差异,其他阶段读数偏高。
- 4热量估算准确性差得多:Apple Watch的MAPE为14.07%至210.84%,Fitbit为16.85%至84.98%,Garmin为30.77%至155.05%。Apple Watch和Garmin在所有阶段都偏高;Fitbit在基线期、轻度和中度强度偏高,剧烈强度(P=.70)和恢复期(P=.10)无差异。
局限与不确定性
- 1三款设备均为2017年之前的型号,固件和算法此后已更新,结果不代表现在的型号。
- 2实验室跑步机上每阶段仅4分钟,没有涵盖长时间稳定跑步,也没有骑行、力量训练等真实场景。
- 3摘要没有报告肤色、佩戴松紧或体能水平对准确性的影响,尽管样本中非白人占47%。
- 4本解读仅基于摘要;Bland-Altman一致性界限未给出。
对日常健康的启示
这几款腕式设备的心率在某些条件下可用,在另一些条件下明显偏差,误差随运动强度而变。热量数字与代谢车相差太大,更适合当作粗略估计,而不是精确数据。
如何联系自己的数据
如果你按心率区间训练,不妨偶尔用胸带核对手表,尤其是轻松和中等强度时,并把热量消耗只当作粗略的相对数字。对比自己的数据时,请用同一设备和同一佩戴位置,看长期趋势。
如何理解这类证据
一致性取决于设备、固件、参照、人群和场景。相关性不等于一致性;验证某个指标不等于已证明诊断或治疗获益。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Background
Physical activity tracking wearable devices have emerged as an increasingly popular method for consumers to assess their daily activity and calories expended. However, whether these wearable devices are valid at different levels of exercise intensity is unknown.
Objective
The objective of this study was to examine heart rate (HR) and energy expenditure (EE) validity of 3 popular wrist-worn activity monitors at different exercise intensities.
Methods
A total of 62 participants (females: 58%, 36/62; nonwhite: 47% [13/62 Hispanic, 8/62 Asian, 7/62 black/ African American, 1/62 other]) wore the Apple Watch, Fitbit Charge HR, and Garmin Forerunner 225. Validity was assessed using 2 criterion devices: HR chest strap and a metabolic cart. Participants completed a 10-minute seated baseline assessment; separate 4-minute stages of light-, moderate-, and vigorous-intensity treadmill exercises; and a 10-minute seated recovery period. Data from devices were compared with each criterion via two-way repeated-measures analysis of variance and Bland-Altman analysis. Differences are expressed in mean absolute percentage error (MAPE).
Results
For the Apple Watch, HR MAPE was between 1.14% and 6.70%. HR was not significantly different at the start (P=.78), during baseline (P=.76), or vigorous intensity (P=.84); lower HR readings were measured during light intensity (P=.03), moderate intensity (P=.001), and recovery (P=.004). EE MAPE was between 14.07% and 210.84%. The device measured higher EE at all stages (P<.01). For the Fitbit device, the HR MAPE was between 2.38% and 16.99%. HR was not significantly different at the start (P=.67) or during moderate intensity (P=.34); lower HR readings were measured during baseline, vigorous intensity, and recovery (P<.001) and higher HR during light intensity (P<.001). EE MAPE was between 16.85% and 84.98%. The device measured higher EE at baseline (P=.003), light intensity (P<.001), and moderate intensity (P=.001). EE was not significantly different at vigorous (P=.70) or recovery (P=.10). For Garmin Forerunner 225, HR MAPE was between 7.87% and 24.38%. HR was not significantly different at vigorous intensity (P=.35). The device measured higher HR readings at start, baseline, light intensity, moderate intensity (P<.001), and recovery (P=.04). EE MAPE was between 30.77% and 155.05%. The device measured higher EE at all stages (P<.001).
Conclusions
This study provides one of the first validation assessments for the Fitbit Charge HR, Apple Watch, and Garmin Forerunner 225. An advantage and novel approach of the study is the examination of HR and EE at specific physical activity intensities. Establishing validity of wearable devices is of particular interest as these devices are being used in weight loss interventions and could impact findings. Future research should investigate why differences between exercise intensities and the devices exist.
来源与署名
Estimating Accuracy at Exercise Intensities: A Comparative Study of Self-Monitoring Heart Rate and Physical Activity Wearable Devices.
Dooley EE, Golaszewski NM, Bartholomew JB.
JMIR mHealth and uHealth · 2017-03-16
DOI: 10.2196/mhealth.7043 ↗PubMed · 28302596 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
加速度计处理方法不同,身体活动与卒中、心肌梗死的关联曲线也不同
在英国生物银行中,基线无心血管疾病的90237名成年人随访至2022年12月,共发生1298例卒中和2031例心肌梗死;中高强度身体活动(MVPA)与这两种结局的关联曲线形状,取决于加速度计数据的处理方法。就卒中而言,只有机器学习法得到直线下降的风险;就心肌梗死而言,机器学习法和LFENMO法呈曲线下降,活动计数法呈直线下降。摘要没有给出风险比,只能说明不同方法的结论不一致,不能说明哪种方法更正确,而且这些只是观察性关联。
Preventive Medicine
智能手表数据能当“证人”吗:心率验证得最充分,其余证据参差
一项围绕数字取证展开的系统评价和荟萃分析,梳理了四大主流品牌智能手表的验证研究,发现心率是研究最多、也最准确的指标。步数、距离、能量消耗、活动分类和睡眠的验证不够一致,结果因品牌、方案和报告方式而异。摘要没有给出汇总数据,且多数研究是在健康人群中、于实验室内完成的,所以无法说明某一块手表对某个人在日常生活中的表现。
Forensic Science International
活动追踪器:每天多走约1800步,对其他健康指标影响较小
这项伞形综述汇总了39篇系统评价和荟萃分析,涉及163992名参与者;结果显示使用活动追踪器与身体活动增加相关(标准化均数差SMD为0.3–0.6),相当于每天多走约1800步、多步行40分钟,体重减轻约1公斤。对血压、胆固醇、糖化血红蛋白、生活质量和疼痛的影响通常很小,且多数不显著。摘要没有说明这些项目里追踪器还搭配了什么,也没有说明各评价之间重叠多少,因此不能把效果完全归功于设备本身。
The Lancet Digital Health
七款睡眠追踪设备:识别睡着很准,识别醒着和睡眠分期较差
在睡眠实验室里,34名健康的年轻成年人连续三晚佩戴七款消费级睡眠追踪设备中的若干款。与多导睡眠监测相比,所有设备识别睡眠都很准(灵敏度均不低于0.93),但识别清醒较差(特异度0.18–0.54),七款中有五款与研究用活动记录仪(特异度0.39)持平或更好;睡眠分期的估计结果不稳定。受试者是18至35岁的健康成年人,卧床时间固定为8小时,每款设备只在其中11至20人身上测试,因此对有睡眠问题的人几乎没有参考价值。
Sleep

